X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10200) 10200
Newsletter (252) 252
Book Chapter (203) 203
Newspaper Article (181) 181
Magazine Article (14) 14
Book / eBook (7) 7
Publication (4) 4
Reference (2) 2
Trade Publication Article (2) 2
Conference Proceeding (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (7851) 7851
life sciences & biomedicine (7235) 7235
humans (6491) 6491
male (4928) 4928
glucose (4893) 4893
female (4192) 4192
diabetes (4118) 4118
insulin resistance (3489) 3489
animals (3165) 3165
endocrinology & metabolism (2841) 2841
insulin (2833) 2833
middle aged (2748) 2748
blood glucose - metabolism (2628) 2628
adult (2535) 2535
dextrose (2161) 2161
type 2 diabetes (2147) 2147
diabetes mellitus (1834) 1834
glucose metabolism (1764) 1764
obesity (1747) 1747
risk factors (1685) 1685
glucose tolerance test (1672) 1672
aged (1589) 1589
insulin - blood (1519) 1519
mice (1475) 1475
hypoglycemic agents - therapeutic use (1413) 1413
metabolism (1359) 1359
research (1351) 1351
diabetes mellitus, type 2 - drug therapy (1350) 1350
physiological aspects (1247) 1247
hyperglycemia (1179) 1179
analysis (1117) 1117
glucose - metabolism (1112) 1112
blood glucose - analysis (1097) 1097
health aspects (1054) 1054
abridged index medicus (1052) 1052
rats (1037) 1037
rodents (1035) 1035
insulin - metabolism (1008) 1008
glucose tolerance (977) 977
blood glucose - drug effects (943) 943
care and treatment (943) 943
diabetes mellitus, type 2 - blood (917) 917
body mass index (885) 885
medicine & public health (877) 877
diet (804) 804
research article (800) 800
homeostasis (790) 790
medicine (788) 788
pharmacology & pharmacy (759) 759
internal medicine (756) 756
treatment outcome (739) 739
body weight (736) 736
lipids (718) 718
diabetes mellitus, type 2 - metabolism (710) 710
glucose intolerance - drug therapy (705) 705
mice, inbred c57bl (702) 702
studies (701) 701
hypertension (693) 693
diabetes therapy (690) 690
fasting (685) 685
pregnancy (666) 666
proteins (662) 662
drug therapy (661) 661
inflammation (649) 649
metabolic disorders (643) 643
nutrition & dietetics (635) 635
glucose intolerance (626) 626
metabolic syndrome (622) 622
cholesterol (621) 621
adolescent (620) 620
blood pressure (611) 611
science & technology - other topics (609) 609
physiology (601) 601
multidisciplinary sciences (599) 599
insulin secretion (584) 584
blood sugar (563) 563
cardiovascular disease (563) 563
hypoglycemic agents - pharmacology (563) 563
endocrinology (562) 562
liver (562) 562
insulin resistance - physiology (556) 556
general & internal medicine (553) 553
cardiovascular system & cardiology (548) 548
liver - metabolism (543) 543
gene expression (541) 541
lipids - blood (536) 536
science (528) 528
medicine, general & internal (520) 520
diabetes mellitus, type 2 - complications (516) 516
fatty acids (516) 516
time factors (515) 515
insulin - therapeutic use (501) 501
triglycerides - blood (498) 498
obesity - metabolism (494) 494
double-blind method (489) 489
biochemistry & molecular biology (488) 488
kinases (487) 487
medical research (487) 487
blood glucose (477) 477
review (477) 477
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10778) 10778
Japanese (66) 66
German (21) 21
Chinese (13) 13
French (13) 13
Spanish (13) 13
Portuguese (11) 11
Russian (11) 11
Italian (7) 7
Polish (7) 7
Hungarian (3) 3
Czech (2) 2
Dutch (2) 2
Norwegian (2) 2
Romanian (2) 2
Arabic (1) 1
Danish (1) 1
Serbian (1) 1
Swedish (1) 1
Turkish (1) 1
Ukrainian (1) 1
Urdu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes care, ISSN 1935-5548, 01/2011, Volume 34, Issue 2, pp. 412 - 417
Journal Article
Journal Article
European journal of nutrition, ISSN 1436-6215, 12/2012, Volume 52, Issue 6, pp. 1607 - 1619
Journal Article
The New England journal of medicine, ISSN 1533-4406, 04/2010, Volume 362, Issue 16, pp. 1477 - 1490
BACKGROUND It is not known whether drugs that block the renin-angiotensin system reduce the risk of diabetes and cardiovascular events in patients with impaired glucose tolerance... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Angiotensin II Type 1 Receptor Blockers - adverse effects | Follow-Up Studies | Phenylalanine - analogs & derivatives | Valsartan | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Body Weight - drug effects | Male | Diabetes Mellitus, Type 2 - epidemiology | Incidence | Cyclohexanes - therapeutic use | Glucose Intolerance - drug therapy | Exercise | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Blood Pressure - drug effects | Phenylalanine - therapeutic use | Drug Therapy, Combination | Hypoglycemic Agents - therapeutic use | Blood Glucose - analysis | Double-Blind Method | Risk Factors | Valine - analogs & derivatives | Diabetes Mellitus, Type 2 - prevention & control | Proportional Hazards Models | Blood Glucose - drug effects | Glucose Intolerance - diet therapy | Tetrazoles - therapeutic use | Valine - therapeutic use | Tetrazoles - adverse effects | Valine - adverse effects | Glucose Intolerance - therapy | Evaluation | Care and treatment | Glucose intolerance | Diabetes | Cardiovascular diseases | Drug therapy | Cardiovascular disease | Index Medicus | Abridged Index Medicus
Journal Article
by Bosch, Jackie and Riddle, Matthew C and Rydén, Lars E and Richardson, L and Chazova, I and Gilbert, R and Gomis, R and Syvänne, M and Bogaty, P and Corson, M and Silva, J and Tsang, B and Yakubovich, N and Chandra, R and Pasha, F and Bassi, F and Bono, J and Bustos, B and Camino, A and Cardone, M and Contreras, A and Corinaldesi, F and Cruz, M and Del Corro, I and Fernandez, A and Giachello, C and Guzman, L and Hasbani, E and Hrabar, A and Imposti, H and Lobo Marquez, L and Lugo, M and Mainini, S and Montaña, O and Nardone, L and Polari, P and Ramirez, A and Rodriguez, C and Sago, L and Sanchez, R and Sernia, V and Sinay, I and Sosa Liprandi, A and Tonin, H and Valdez, J and Villamil, A and Burnet, R and Farshid, A and Ho, J and Jerums, G and Luu, S and Razak, S and Sebastian, M and Tiong, F and Torpy, D and Williams, L and Blocher, J and Bohnel, C and Brath, H and Breuss, J and Feinboeck, C and Gulz, E and Kreuzwieser, E and Loreck, C and Riedl, M and Seidlhofer, C and Murashko, N and Campbell, G and Costa, F and Forti, A and Franco, D and Franken, M and Garcia, V and Leaes, P and Lima, F and Lima Filho, M and Manenti, E and Rabelo, L and Roldan, F and Sampaio, C and Seabra, A and Bailey, A and Beaurivage, C and Bhargava, R and Breton, D and Carlson, B and Chagnon, P and Chessex, C and Cudmore, D and Dyrda, I and Ho, K and Hramiak, I and Imran, S and Joyce, C and Lecours, S and Nisker, W and O'Keefe, D and Paul, T and Pesant, M and Shah, A and ... and The ORIGIN Trial Investigators and ORIGIN Trial Investigators
The New England journal of medicine, ISSN 1533-4406, 07/2012, Volume 367, Issue 4, pp. 309 - 318
Participants with impaired fasting glucose who were at risk for cardiovascular events were assigned to receive daily n−3 fatty acids or placebo and to receive... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Male | Incidence | Glucose Intolerance - drug therapy | Treatment Failure | Cardiovascular Diseases - mortality | Female | Drug Therapy, Combination | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Double-Blind Method | Proportional Hazards Models | Glucose Intolerance - complications | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Intention to Treat Analysis | Triglycerides - blood | Fatty Acids, Omega-3 - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Prevention | Complications and side effects | Care and treatment | Patient outcomes | Dietary supplements | Causes of | Diabetes | Cardiovascular diseases | Fatty acids | Health aspects | Myocardial infarction | Arrhythmia | Diabetes mellitus | Lipids | Esters | Cardiovascular disease | Insulin | Glucose tolerance | Diet | Death | Supplementation | Diabetes mellitus (non-insulin dependent) | Heart diseases | Index Medicus | Abridged Index Medicus | Cardiovascular Diseases | Insulin, Long-Acting | Triglycerides | Glucose Intolerance | Cholesterol | Life Sciences | Hypoglycemic Agents | Diabetes Mellitus, Type 2 | Fatty Acids, Omega-3
Journal Article
Diabetes (New York, N.Y.), ISSN 1939-327X, 05/2016, Volume 65, Issue 5, pp. 1190 - 1195
Pharmacologically induced glycosuria elicits adaptive responses in glucose homeostasis and hormone release. In type 2 diabetes (T2D), along with decrements in... 
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Glucose Intolerance - metabolism | Glycosuria - chemically induced | Carbohydrate Metabolism - drug effects | Lipolysis - drug effects | Benzhydryl Compounds - administration & dosage | Humans | Glucagon-Like Peptide 1 - blood | Diabetes Mellitus, Type 2 - metabolism | Insulin - blood | Glucagon - blood | Glucose Intolerance - blood | Glucose Intolerance - drug therapy | Benzhydryl Compounds - adverse effects | Hypoglycemic Agents - administration & dosage | Time Factors | Glucosides - therapeutic use | C-Reactive Protein - analysis | Benzhydryl Compounds - therapeutic use | Insulin Secretion | Glucosides - adverse effects | Hypoglycemic Agents - therapeutic use | 3-Hydroxybutyric Acid - blood | Sodium-Glucose Transporter 2 - metabolism | Glucose Intolerance - urine | 3-Hydroxybutyric Acid - agonists | Renal Elimination - drug effects | Sodium-Glucose Transporter 2 Inhibitors | Membrane Transport Modulators - administration & dosage | Diabetes Mellitus, Type 2 - urine | Diabetes Mellitus, Type 2 - blood | Insulin - metabolism | Algorithms | Glucosides - administration & dosage | 3-Hydroxybutyric Acid - metabolism | Lipid Metabolism - drug effects | Membrane Transport Modulators - therapeutic use | Glucagon - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Membrane Transport Modulators - adverse effects | Hypoglycemic Agents - adverse effects | Energy Metabolism - drug effects | Type 2 diabetes | Care and treatment | Glucagon | Dosage and administration | Triglycerides | Research | Insulin | Homeostasis | Glucose | Hormones | Diabetes | Substrates | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 04/2010, Volume 362, Issue 16, pp. 1463 - 1476
... that involve increasing physical activity and reducing weight4 -6 and with metformin,6 acarbose,7 or rosiglitazone8 therapy, but no trials to date have been powered... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Follow-Up Studies | Phenylalanine - adverse effects | Phenylalanine - analogs & derivatives | Valsartan | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Body Weight - drug effects | Male | Diabetes Mellitus, Type 2 - epidemiology | Incidence | Cyclohexanes - therapeutic use | Glucose Intolerance - drug therapy | Exercise | Treatment Failure | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Cyclohexanes - adverse effects | Phenylalanine - therapeutic use | Drug Therapy, Combination | Hypoglycemic Agents - therapeutic use | Blood Glucose - analysis | Double-Blind Method | Risk Factors | Valine - analogs & derivatives | Diabetes Mellitus, Type 2 - prevention & control | Kaplan-Meier Estimate | Proportional Hazards Models | Blood Glucose - drug effects | Glucose Intolerance - diet therapy | Tetrazoles - therapeutic use | Valine - therapeutic use | Hypoglycemic Agents - adverse effects | Glucose Intolerance - therapy | Evaluation | Care and treatment | Glucose intolerance | Diabetes | Cardiovascular diseases | Drug therapy | Nateglinide | Studies | Cardiovascular disease | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 11/2006, Volume 355, Issue 22, pp. 2297 - 2307
Journal Article